CDC funding accelerates antibiotic resistance efforts
CDC is providing $67 million to help health departments nationwide tackle antibiotic resistance and patient safety threats, including healthcare-associated infections. The funding also includes support for seven new regional laboratories with specialized capabilities allowing rapid detection and identification of emerging antibiotic resistant threats.
These funds will be distributed to all 50 state health departments, six local health departments (Chicago, the District of Columbia, Houston, Los Angeles County, New York City and Philadelphia), and Puerto Rico through the Epidemiology and Laboratory Capacity (ELC) Cooperative Agreement. The awards support activities related to CDC’s Antibiotic Resistance Solutions Initiative and implementation of the surveillance, prevention, and stewardship activities outlined in the National Action Plan for the Combating Antibiotic-Resistant Bacteria.
- Every state health department lab will be able to test for carbapenem-resistant Enterobacteriaceae (“nightmare bacteria”) and work towards performing whole genome sequencing on intestinal bacteria, including Salmonella, Shigella and many Campylobacter. These advancements will allow for faster identification and response to outbreaks and rapid identification of known markers of antibiotic resistance.
- This funding will dramatically expand existing HAI/AR capabilities to track infections in healthcare settings, protect patients through targeted prevention, and increase coordination across medical care. For the first time, CDC will be providing direct assistance to support high-level expertise in antimicrobial resistance activities in six states.
- CDC will provide support teams in nine health departments for rapid response activities designed to quickly identify and respond to the threat of antibiotic-resistant gonorrhea in the U.S.
Read the announcement at: http://www.cdc.gov/media/